Basics Castle Biosciences, Inc. IPO Date: July 22, 2019 Sector: Healthcare Market Cap: $667.48M Activated in VL: True Average Daily Range Avg Daily Range: $1.00 | 3.00% Avg Daily Range (30 D): $0.48 | 2.09% Avg Daily Range (90 D): $0.45 | 2.20% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .24M Avg Daily Volume (90 D): .35M Trade Size Avg Trade Size (Sh.): 56 Avg Trade Size (Sh.) (30 D): 44 Avg Trade Size (Sh.) (90 D): 52 Institutional Trades Total Inst.Trades: 1,313 Avg Inst. Trade: $1.28M Avg Inst. Trade (30 D): $1.06M Avg Inst. Trade (90 D): $1.35M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.37M Avg Closing Trade (30 D): $1.18M Avg Closing Trade (90 D): $1.37M Avg Closing Volume: 45.55K     News Oct 13, 2025 @ 11:00 AM Castle Biosciences to Release Third Quarter 2025 F... Source: Castle Biosciences Inc. Sep 17, 2025 @ 11:00 AM Castle Biosciences Named One of Newsweek’s ... Source: Castle Biosciences Inc. Sep 9, 2025 @ 11:00 AM New Data at American Foregut Society's 2025 Annual... Source: Caitlin C. Houghton, M.D. Aug 28, 2025 @ 2:44 PM FDA Tightens Survival Standards as Cancer Drug Pip... Source: Prnewswire Jul 29, 2025 @ 11:00 AM Castle Biosciences to Present at the Canaccord Gen... Source: Castle Biosciences Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $.16 $-.9 Diluted EPS $.15 $-.9 Revenue $ $ 86.19M $ 87.99M Gross Profit $ $ 68.56M $ 71.61M Net Income / Loss $ $ 4.52M $ -25.85M Operating Income / Loss $ $ -4.25M $ -27.93M Cost of Revenue $ $ 17.63M $ 16.38M Net Cash Flow $ $ -7.46M $ -30.02M PE Ratio